O'Fallon JR - Search Results

1

Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia.

Dewald GW, Brockman SR, Paternoster SF, Bone ND, O'Fallon JR, Allmer C, James CD, Jelinek DF, Tschumper RC, Hanson CA, Pruthi RK, Witzig TE, Call TG, Kay NE. Dewald GW, et al. Br J Haematol. 2003 Apr;121(2):287-95. doi: 10.1046/j.1365-2141.2003.04265.x. Br J Haematol. 2003. PMID: 12694251 Free article.

2

Prognostic value of cytogenetic analysis in human cerebral astrocytomas.

Kimmel DW, O'Fallon JR, Scheithauer BW, Kelly PJ, Dewald GW, Jenkins RB. Kimmel DW, et al. Ann Neurol. 1992 May;31(5):534-42. doi: 10.1002/ana.410310512. Ann Neurol. 1992. PMID: 1596090

3

PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.

Smith JS, Tachibana I, Passe SM, Huntley BK, Borell TJ, Iturria N, O'Fallon JR, Schaefer PL, Scheithauer BW, James CD, Buckner JC, Jenkins RB. Smith JS, et al. J Natl Cancer Inst. 2001 Aug 15;93(16):1246-56. doi: 10.1093/jnci/93.16.1246. J Natl Cancer Inst. 2001. PMID: 11504770

4

Clinical characteristics and prognosis of 50 patients with a myeloproliferative syndrome and deletion of part of the long arm of chromosome 5.

Dewald GW, Davis MP, Pierre RV, O'Fallon JR, Hoagland HC. Dewald GW, et al. Blood. 1985 Jul;66(1):189-97. Blood. 1985. PMID: 4005429 Free article.

5

Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations.

Raffel C, Frederick L, O'Fallon JR, Atherton-Skaff P, Perry A, Jenkins RB, James CD. Raffel C, et al. Clin Cancer Res. 1999 Dec;5(12):4085-90. Clin Cancer Res. 1999. PMID: 10632344

6

Gene amplification as a prognostic factor in primary and secondary high-grade malignant gliomas.

Galanis E, Buckner J, Kimmel D, Jenkins R, Alderete B, O'Fallon J, Wang CH, Scheithauer BW, James CD. Galanis E, et al. Int J Oncol. 1998 Oct;13(4):717-24. Int J Oncol. 1998. PMID: 9735401

7

Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation.

James CD, Galanis E, Frederick L, Kimmel DW, Cunningham JM, Atherton-Skaff PJ, O'Fallon JR, Jenkins RB, Buckner JC, Hunter SB, Olson JJ, Scheithauer BW. James CD, et al. Int J Oncol. 1999 Sep;15(3):547-53. doi: 10.3892/ijo.15.3.547. Int J Oncol. 1999. PMID: 10427138 Clinical Trial.

8

Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities.

Buckner JC, Gesme D Jr, O'Fallon JR, Hammack JE, Stafford S, Brown PD, Hawkins R, Scheithauer BW, Erickson BJ, Levitt R, Shaw EG, Jenkins R. Buckner JC, et al. J Clin Oncol. 2003 Jan 15;21(2):251-5. doi: 10.1200/JCO.2003.06.023. J Clin Oncol. 2003. PMID: 12525516 Clinical Trial.

9

Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB. Smith JS, et al. J Clin Oncol. 2000 Feb;18(3):636-45. doi: 10.1200/JCO.2000.18.3.636. J Clin Oncol. 2000. PMID: 10653879

10

Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.

Smith JS, Alderete B, Minn Y, Borell TJ, Perry A, Mohapatra G, Hosek SM, Kimmel D, O'Fallon J, Yates A, Feuerstein BG, Burger PC, Scheithauer BW, Jenkins RB. Smith JS, et al. Oncogene. 1999 Jul 15;18(28):4144-52. doi: 10.1038/sj.onc.1202759. Oncogene. 1999. PMID: 10435596

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page